Published in J Clin Pathol on May 01, 2004
Anaplasma phagocytophilum--a widespread multi-host pathogen with highly adaptive strategies. Front Cell Infect Microbiol (2013) 1.57
Whole genome transcription profiling of Anaplasma phagocytophilum in human and tick host cells by tiling array analysis. BMC Genomics (2008) 1.45
Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum. Clin Microbiol Rev (2011) 1.44
Infection with Anaplasma phagocytophilum induces multilineage alterations in hematopoietic progenitor cells and peripheral blood cells. Infect Immun (2009) 1.17
Anaplasma phagocytophilum AptA modulates Erk1/2 signalling. Cell Microbiol (2010) 0.98
First reported case of Ehrlichia ewingii involving human bone marrow. J Clin Microbiol (2014) 0.83
Neutrophils exposed to A. phagocytophilum under shear stress fail to fully activate, polarize, and transmigrate across inflamed endothelium. Am J Physiol Cell Physiol (2010) 0.79
Anaplasma phagocytophilum infection induces apoptosis in HL-60 cells. World J Microbiol Biotechnol (2011) 0.75
Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep (1995) 7.11
Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging? JAMA (1994) 6.55
Direct cultivation of the causative agent of human granulocytic ehrlichiosis. N Engl J Med (1996) 5.35
Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA (1996) 4.88
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood (1992) 4.11
Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med (1996) 3.41
PCR amplification and comparison of nucleotide sequences from the groESL heat shock operon of Ehrlichia species. J Clin Microbiol (1997) 2.59
Human ehrlichioses: newly recognized infections transmitted by ticks. Annu Rev Med (1998) 2.25
Human granulocytic ehrlichiosis in Connecticut: report of a fatal case. Clin Infect Dis (1995) 1.97
Intracellular infection by the human granulocytic ehrlichiosis agent inhibits human neutrophil apoptosis. Infect Immun (2000) 1.69
Intracellular parasitism by the human granulocytic ehrlichiosis bacterium through the P-selectin ligand, PSGL-1. Science (2000) 1.67
Comparative pathology, and immunohistology associated with clinical illness after Ehrlichia phagocytophila-group infections. Am J Trop Med Hyg (2000) 1.55
A single tissue culture system for the propagation of the agents of the human ehrlichioses. Am J Trop Med Hyg (1998) 1.46
Serology of culture-confirmed cases of human granulocytic ehrlichiosis. J Clin Microbiol (2000) 1.32
Leukocyte infection by the granulocytic ehrlichiosis agent is linked to expression of a selectin ligand. J Clin Invest (1999) 1.24
Diminished adhesion of Anaplasma phagocytophilum-infected neutrophils to endothelial cells is associated with reduced expression of leukocyte surface selectin. Infect Immun (2003) 1.20
Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. J Infect Dis (1997) 1.20
Structurally distinct requirements for binding of P-selectin glycoprotein ligand-1 and sialyl Lewis x to Anaplasma phagocytophilum and P-selectin. J Biol Chem (2003) 1.18
Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin Infect Dis (2001) 1.11
Anaplasma phagocytophilum reduces neutrophil apoptosis in vivo. Infect Immun (2003) 1.09
Notification list. Notification that new names and new combinations have appeared in volume 51, part 6, of the IJSEM. Int J Syst Evol Microbiol (2002) 0.87
Human granulocytic ehrlichiosis presenting with acute renal failure and mimicking thrombotic thrombocytopenic purpura. A case report and review. Am J Nephrol (1999) 0.82
Clinical and laboratory evolution of a culture-confirmed case of human granulocytic ehrlichiosis. Conn Med (1999) 0.79
A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84
Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med (2001) 6.76
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med (1984) 6.11
The autopsy as a measure of accuracy of the death certificate. N Engl J Med (1985) 5.78
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation (1992) 3.98
Streptococcal anti-desoxyribonuclease B: microtechnique determination. J Lab Clin Med (1968) 3.88
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome. N Engl J Med (1983) 3.67
Human granulocytic ehrlichiosis: a case series from a medical center in New York State. Ann Intern Med (1996) 3.41
Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect Immun (1999) 3.41
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2007) 3.12
Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother (1994) 3.02
Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol (1995) 2.97
Primary structure of human T-cell receptor alpha-chain. Nature (1985) 2.93
rRNA operon multiplicity in Escherichia coli and the physiological implications of rrn inactivation. J Bacteriol (1995) 2.87
Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev (1999) 2.82
Frequency of puncture injuries in surgeons and estimated risk of HIV infection. Arch Surg (1989) 2.79
Impact of color blindness on recognition of blood in body fluids. Arch Intern Med (2001) 2.78
Serodiagnosis in early Lyme disease. J Clin Microbiol (1993) 2.69
Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N Engl J Med (1997) 2.69
Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions. J Clin Microbiol (1992) 2.69
Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J Infect Dis (1999) 2.64
Perinatal transmission of the agent of human granulocytic ehrlichiosis. N Engl J Med (1998) 2.61
Infection due to Leuconostoc species: six cases and review. Rev Infect Dis (1990) 2.58
Widespread divergence between incipient Anopheles gambiae species revealed by whole genome sequences. Science (2010) 2.58
Lyme borreliosis. Lancet (1998) 2.57
Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily. Cell (1996) 2.56
rRNA gene organization in the Lyme disease spirochete, Borrelia burgdorferi. J Bacteriol (1992) 2.50
Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis. J Clin Microbiol (1998) 2.44
Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol (1995) 2.43
Evolution of the serologic response to Borrelia burgdorferi in treated patients with culture-confirmed erythema migrans. J Clin Microbiol (1996) 2.43
Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Gynecol Oncol (2002) 2.41
Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41
Hepatitis B virus DNA in the sera of HBsAg carriers: a marker of active hepatitis B virus replication in the liver. Hepatology (1982) 2.38
Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens. J Clin Microbiol (1999) 2.35
Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis. Am J Clin Pathol (1997) 2.35
Antigenic diversity of granulocytic Ehrlichia isolates from humans in Wisconsin and New York and a horse in California. J Infect Dis (1997) 2.31
Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study. Neurobiol Aging (2000) 2.26
Ultrastructural and antigenic characterization of a granulocytic ehrlichiosis agent directly isolated and stably cultivated from a patient in New York state. J Infect Dis (1997) 2.26
A significant number of human immunodeficiency virus epitope-specific cytotoxic T lymphocytes detected by tetramer binding do not produce gamma interferon. J Virol (2000) 2.26
Single-molecule recognition imaging microscopy. Proc Natl Acad Sci U S A (2004) 2.25
Brain aging and midlife tofu consumption. J Am Coll Nutr (2000) 2.25
Foreign bodies in the tracheobronchial tree. Chest (1987) 2.19
Sequence and analysis of chromosome 5 of the plant Arabidopsis thaliana. Nature (2000) 2.16
The influence of human immunodeficiency virus-1 on hematopoiesis. Blood (1998) 2.15
Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology (2001) 2.15
Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry (1997) 2.15
Design of aging intervention studies: the NIA interventions testing program. Age (Dordr) (2008) 2.14
Role of migratory birds in introduction and range expansion of Ixodes scapularis ticks and of Borrelia burgdorferi and Anaplasma phagocytophilum in Canada. Appl Environ Microbiol (2008) 2.13
Development of the human corpus callosum during childhood and adolescence: a longitudinal MRI study. Prog Neuropsychopharmacol Biol Psychiatry (1999) 2.10
MCM7 amplification and overexpression are associated with prostate cancer progression. Oncogene (2006) 2.07
Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III). N Engl J Med (1985) 1.99
Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis. J Clin Microbiol (1997) 1.98
Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J Clin Microbiol (1999) 1.95
Laboratory diagnostic techniques for patients with early Lyme disease associated with erythema migrans: a comparison of different techniques. Clin Infect Dis (2001) 1.94
Prevalence of the rickettsial agent of human granulocytic ehrlichiosis in ticks from a hyperendemic focus of Lyme disease. N Engl J Med (1997) 1.93
Impact of genotypic variation of Borrelia burgdorferi sensu stricto on kinetics of dissemination and severity of disease in C3H/HeJ mice. Infect Immun (2001) 1.93
Photo-affinity labeling of tRNA binding sites in macromolecules. I. Linking of the phenacyl-p-azide of 4-thiouridine in (Escherichia coli) valyl-tRNA to 16S RNA at the ribosomal P site. Proc Natl Acad Sci U S A (1974) 1.87
Borrelia lonestari infection after a bite by an Amblyomma americanum tick. J Infect Dis (2001) 1.84
Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry (2001) 1.84
Molecular cloning and sequencing of pheU, a gene for Escherichia coli tRNAPhe. Nucleic Acids Res (1983) 1.83
Anthrax lethal factor inhibition. Proc Natl Acad Sci U S A (2005) 1.83
Leuconostoc, an emerging vancomycin-resistant pathogen. Lancet (1987) 1.80
Depression and multiple sclerosis. Neurology (1996) 1.79
Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology (1999) 1.79
Cause of ill health and natural death in badgers in Gloucestershire. Vet Rec (1979) 1.75
Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections. J Infect Dis (1995) 1.75
Molecular typing of Borrelia burgdorferi from Lyme disease patients by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol (1996) 1.73
Prevalence of tick-borne pathogens in Ixodes scapularis in a rural New Jersey County. Emerg Infect Dis (1998) 1.72
Accuracy of IgM immunoblotting to confirm the clinical diagnosis of early Lyme disease. Arch Intern Med (1996) 1.71
Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Virology (1995) 1.71
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer (1992) 1.68
Childhood-onset schizophrenia: progressive brain changes during adolescence. Biol Psychiatry (1999) 1.66
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. N Engl J Med (1996) 1.64
Inhibition of efficient polymerase chain reaction amplification of Borrelia burgdorferi DNA in blood-fed ticks. Am J Trop Med Hyg (1997) 1.63
Strongyloides stercoralis hyperinfection in a patient with the acquired immune deficiency syndrome. Am J Med (1987) 1.61
A limitation of 2-stage serological testing for Lyme disease: enzyme immunoassay and immunoblot assay are not independent tests. Clin Infect Dis (2000) 1.61
High frequency of false positive IgM immunoblots for Borrelia burgdorferi in clinical practice. Clin Microbiol Infect (2012) 1.60
Reinfection with the agent of human granulocytic ehrlichiosis. Ann Intern Med (1998) 1.60
Acquired immunodeficiency syndrome in male prisoners. New insights into an emerging syndrome. Ann Intern Med (1983) 1.58
Highly asymmetric transcription by RNA polymerase containing phage-SP01-induced polypeptides and a new host protein. Proc Natl Acad Sci U S A (1975) 1.57
Serratia plymuthica sepsis associated with infection of central venous catheter. J Clin Microbiol (1987) 1.57